|
|
|
|
|
|
Array Biopharma Inc (ARRY)
|
|
8.945 +0.005 (+0.056%)
|
8/16/2017 1:08pm
|
|
Open:
|
8.910
|
Pre. Close:
|
8.940
|
|
High:
|
9.000
|
Low:
|
8.840
|
|
Volume:
|
819,036
|
Market Cap:
|
1.53B
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
9.17 - 9.32
|
9.32 - 9.51
|
|
Low:
|
8.25 - 8.34
|
8.34 - 8.46
|
|
Close:
|
8.7 - 8.94
|
8.94 - 9.25
|
|
|
|
|
|
|
Technical analysis (as of: 2017-08-16 1:07:08 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 10.61 One year: 12.39
|
|
Support:
|
Support1: 7.89 Support2: 7.15
|
|
Resistance:
|
Resistance1:
9.08 Resistance2: 10.61
|
|
Pivot:
|
8.11 
|
|
Moving Averages:
|
MA(5): 8.77 MA(20): 8.08
MA(100): 8.24  MA(250): 8.09
|
|
MACD:
|
MACD(12,26):
0.18 Signal(12,26,9): 0.02
|
|
%K %D:
|
%K(14,3): 95.15 %D(3): 90.53
|
|
RSI:
|
RSI(14): 61.73
|
|
52-Week:
|
High: 13.400
Low: 3.100 Change(%): 157.5
|
|
Average Vol(K):
|
3-Month: 260359
10-Days 185048
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.ARRY has closed below upper band by 14.0%. Bollinger Bands are 41.4% wider than normal. The large width of the bands suggest high volatility as compared to ARRY's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
Tue, 21 Mar 2017 09:00:00 GMT
Piper Jaffray Reaffirms Their Buy Rating on Array Biopharma
Mon, 07 Aug 2017 20:15:00 GMT
Here's Why Array BioPharma Inc. Fell 13.7% in July
Sat, 12 Aug 2017 09:33:45 GMT
Array BioPharma Inc (ARRY) Files 10-K for the Fiscal Year Ended on June 30, 2017
Wed, 16 Aug 2017 14:37:30 GMT
Price Alert: Array BioPharma Inc (NASDAQ:ARRY) Stock Nears Resistance ...
Tue, 15 Aug 2017 13:23:25 GMT
Revenue Approximations Analysis: Array BioPharma Inc. (ARRY), JetBlue Airways ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
